Genesis Medtech acquires 80% stake in Jiangsu Ni Ke Medical Device for CNY 520 million

Genesis Medtech Investment (HK) Limited entered into an equity transfer agreement to acquire an 80% stake in Jiangsu Ni Ke Medical Device Co., Ltd. from Livzon Pharmaceutical Group and other shareholders for approximately CNY 520 million on May 23, 2020.

“Genesis Medtech Investment (HK) Limited entered into an equity transfer agreement to acquire 80% stake in Jiangsu Ni Ke Medical Device Co., Ltd. from Livzon Pharmaceutical Group Inc. for approximately CNY 520 million.”marketscreener.com

• 1 source
• marketscreener.comGenesis Medtech Investment (HK) Limited entered into an equity transfer agreement to acquire 80% stake in Jiangsu Ni Ke Medical Device Co., Ltd. from Livzon Pharmaceutical Group Inc., Zijin Zhonghao Investment Co., Ltd., Yongyi Yu, Wu Guangmin and other shareholders for approximately CNY 520 million.MarketScreenerMay 25, 2020

Summarized from public sources; check the original articles before acting on it.